Monday Lunch Live

With Professor Brian Abbey

21 February 2022

A collaborative team of researchers led by Professor Brian Abbey (La Trobe Institute for Molecular Sciences) and Associate Professor Belinda Parker (Peter MacCallum Cancer Centre), have been trialling a new alternative technology for cancer detection. NanoMslide: a cutting-edge nanotechnology to transform the humble microscope slide into a potential new tool for cancer diagnosis.

Accurate staging of very early-stage breast cancer can be challenging because abnormal cells may be morphologically similar to healthy cells. Having recently completed the first proof-of-concept study, the team are now working towards larger scale studies as well as testing their technology with a range of different types of tissues and diseases.